Dr. Steven Jones, Co-Director for the Spectrum Centre for Mental Health Research at Lancaster University and CREST.BD member, describes recovery focused CBT for bipolar disorder. For many people living with bipolar disorder, the concept of personal recovery is a meaningful one. This seems to mean being able to engage in valued activities, having strategies for self-management of health and having an understanding of mood experiences. This webinar will describe the development and evaluation of a new measure of personal recovery in bipolar disorder and a new individualized psychological therapy designed to enhance personal recovery outcomes in individuals with a relatively recent diagnosis of bipolar disorder (less than 5 years).
Steven received his PhD and clinical training at the Institute of Psychiatry in London where he had an academic post before moving to the North West of the UK. There, he worked in the NHS as well as at the University of Manchester until 2008, when he became founding Director of the Spectrum Centre for Mental Health Research at Lancaster University. Since 2013, in recognition of the growth of the Spectrum Centre, a co-directorship model was initiated between Steven and Fiona Lobban (formerly associate director). Steven’s research interests have always centred on the psychology of severe mental health problems. For over 15 years, his primary interest has been in the psychology and psychological treatment of bipolar disorder and associated conditions. In line with this interest he has over 100 publications, mainly on the development of cognitive therapy approaches for bipolar disorder and on psychological models relevant to the development and recurrence of bipolar experiences.
Cancer and role of occupational therapist in cancer Ambreen Sadaf
Introduction to oncology
Role of occupational therapy
Hazards to life due to cancer
Interventional aim to cancer
Lifestyle management
Benefits of occupational therapy in oncology
Occupational service in cancer
Interventions
Role of occupational therapy in cancer or oncology
A brief introduction to what Keele's Stratified care for low back pain: Subgrouping and targeting treatment for low back pain in primary care (STarT Back).
The STarT Back approach uses a simple tool to match patients suggesting with back pain to treatment packages appropriate for them. This has been shown to decrease disability from back pain, reduce time off work, and save money by making better use of health resources.
Self management is a recent concept in pulmonary rehabilitation. this concept uses patient's ability to manage their self with no direct interaction with their healthcare provider.
Recently obesity is becoming one of the psychiatric disorder , we are discussing depression and ADHD associated with obesity , cognitive reconstruction and cognitive behavior therapy steps is discussed , medical therapy used in obesity
severe and enduring anorexia nervosa : clinical and neuropsychological aspectsHeba Essawy, MD
severe and enduring anorexia nervosa is a persistent dietary restriction , underweight and over evaluation-of weight , history of more than 3 years and exposure to at least two evidence based treatments delivered
Dr. Steven Jones, Co-Director for the Spectrum Centre for Mental Health Research at Lancaster University and CREST.BD member, describes recovery focused CBT for bipolar disorder. For many people living with bipolar disorder, the concept of personal recovery is a meaningful one. This seems to mean being able to engage in valued activities, having strategies for self-management of health and having an understanding of mood experiences. This webinar will describe the development and evaluation of a new measure of personal recovery in bipolar disorder and a new individualized psychological therapy designed to enhance personal recovery outcomes in individuals with a relatively recent diagnosis of bipolar disorder (less than 5 years).
Steven received his PhD and clinical training at the Institute of Psychiatry in London where he had an academic post before moving to the North West of the UK. There, he worked in the NHS as well as at the University of Manchester until 2008, when he became founding Director of the Spectrum Centre for Mental Health Research at Lancaster University. Since 2013, in recognition of the growth of the Spectrum Centre, a co-directorship model was initiated between Steven and Fiona Lobban (formerly associate director). Steven’s research interests have always centred on the psychology of severe mental health problems. For over 15 years, his primary interest has been in the psychology and psychological treatment of bipolar disorder and associated conditions. In line with this interest he has over 100 publications, mainly on the development of cognitive therapy approaches for bipolar disorder and on psychological models relevant to the development and recurrence of bipolar experiences.
Cancer and role of occupational therapist in cancer Ambreen Sadaf
Introduction to oncology
Role of occupational therapy
Hazards to life due to cancer
Interventional aim to cancer
Lifestyle management
Benefits of occupational therapy in oncology
Occupational service in cancer
Interventions
Role of occupational therapy in cancer or oncology
A brief introduction to what Keele's Stratified care for low back pain: Subgrouping and targeting treatment for low back pain in primary care (STarT Back).
The STarT Back approach uses a simple tool to match patients suggesting with back pain to treatment packages appropriate for them. This has been shown to decrease disability from back pain, reduce time off work, and save money by making better use of health resources.
Self management is a recent concept in pulmonary rehabilitation. this concept uses patient's ability to manage their self with no direct interaction with their healthcare provider.
Recently obesity is becoming one of the psychiatric disorder , we are discussing depression and ADHD associated with obesity , cognitive reconstruction and cognitive behavior therapy steps is discussed , medical therapy used in obesity
severe and enduring anorexia nervosa : clinical and neuropsychological aspectsHeba Essawy, MD
severe and enduring anorexia nervosa is a persistent dietary restriction , underweight and over evaluation-of weight , history of more than 3 years and exposure to at least two evidence based treatments delivered
Patient activation: New insights into the role of patients in self-managementMS Trust
This presentation by Helen Gilburt, Fellow at The King's Fund, looks at why some people are active at managing their health while others are quite passive, and how levels of patient activation impact on health outcomes.
It was presented at the MS Trust Annual Conference in November 2014.
Thinking About Success and Failure in Obesity CareObesityHelp
Even though obesity has officially been classified as disease by important groups like the American Medical Association, many people – doctors included – put all the emphasis on the scale and on other measures like body mass index (BMI). In this talk we will look at how success is measured now and other ways to define success after bariatric surgery. Time allowing, we will also talk about some of the long-term issues related to health and nutrition after bariatric surgery, with a focus on things that contribute to weight regain.
45 minutes of suffering (or Anesthesia Grand Rounds on Palliative Care)Mike Aref
Presentation on what palliative care is, comparison with hospice, primary palliative care screening, goals-of-care, definitions of DNR, basics of acute pain management and WHO analgesic ladder.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
CBT-E for adolescents: Latest clinical evidence
1. Enhanced CBT in Adolescents:
Latest Clinical Evidence
Riccardo Dalle Grave, MD
Department of Eating and Weight Disorders
Villa Garda Hospital- Grada (VR). Italy
2. Background
• Anorexia nervosa (AN) has a profound impact on physical health and psychosocial
functioning
• It is important to treat it early and effectively as otherwise it can have long-lasting
effects.
• A particular form of family therapy, termed Moudsley therapy o family-based treatment
(FBT, Lock, Le Grange, Agras, & Dare, 2001) is the leading empirically-supported
intervention for adolescents with the disorder (NICE, 2017).
Introduction
3. Introduction (cont.)
FBT limitations
• It is not acceptable to some families and patients
• Fewer than half the patients make a full treatment response (Lock, 2011; Lock et al., 2010)
“FBT needs to be modified to make it more acceptable and effective, or alternative treatment
approaches need to be found.” (Lock, 2011)
CBT-E is the most valid alternative to FBT
• CBT-E works across the eating disorders
• Younger patients have essentially the same ED psychopathology as older patients
4. CBT-E and the younger patient
Topics
1. Eating disorders in younger patients
2. An overview of CBT-E for the younger patients
3. Effectiveness of CBT-E for the younger patients
4. Influence on the health policy
5. CBT-E and the younger patient
Topics
1. Eating disorders in younger patients
2. An overview of CBT-E for the younger patients
3. Effectiveness of CBT-E for the younger patients
4. Influence on the health policy
6. Features Shared with Older Patients
• Essentially the same ED psychopathology (over-evaluation of shape and weight; strict
dieting; self-induced vomiting; laxative misuse; binge eating; overexercising; etc)
• These features can be addressed by CBT-E
credo
Eating disorders in younger patients
7. Diagnosis N %
Anorexia Nervosa 81 60.0
Bulimia Nervosa 12 8.9
Binge-Eating Disorder 7 5.2
Avoidant restrictive food intake disorder 7 5.2
Other Specified Eating Disorders
Atypical Anorexia Nervosa 16 11.9
Bulimia nervosa (of low frequency and/or limited duration) 0 0
Binge-Eating Disorder (of low frequency and/or limited duration) 0 0
Purging Disorder 0 0
Night Eating Syndrome 0 0
Unspecified Eating Disorders 12 8.9
The distribution of eating disorder diagnosis among consecutive adolescent patients with eating
disorders attending an Italian (Verona) outpatient CBT-E clinical service from 2016 to 2018
8. Distinctive Features
• Most adolescent patients are highly concerned about issues of control and autonomy
• This is not a problem as CBT-E is designed to enhance patients’ sense of control and autonomy. CBT-E is
collaborative with the therapist and patient working together to overcome the eating problem
• Many adolescent patients are highly ambivalent about treatment
• This is not a problem as CBT-E is designed to be engaging and to address ambivalence
• Some patients have over-evaluation of control over eating per se
• This is not a problem as this form of over-evaluation can be addressed using an adaptation of the “body
image” module of CBT-E
credo
Eating disorders in younger patients
9. Distinctive Features (cont.)
• In the great majority of cases the patient’s parents need to be involved in treatment
• This requires modifying CBT-E, but only to a limited extent
• The youngest patients require a treatment that matches their cognitive development
• This is easily managed in CBT-E as it is not a complex treatment to receive
• The patient’s physical health is of particular concern in younger patients
• This necessitates careful assessment and monitoring, and a lower threshold for providing patients with a more
intensive intervention (e.g., hospitalisation)
credo
Eating disorders in younger patients
10. CBT-E and the younger patient
Topics
1. Eating disorders in younger patients
2. An overview of CBT-E for the younger patients
3. Effectiveness of CBT-E for the younger patients
4. Influence on the health policy
11. Design and implementation of the treatment
• In collaboration with the CREDO, the Department of
Eating and Weight Disorders of Villa Garda Hospital,
Italy, has adapted CBT-E for adolescents of at least 13
years of age
An overview of CBT-E for the younger patients
Strict dieting; non-
compensatory weight-control
behavior
Binge eating
Compensatory
vomiting/laxative
misuse
Significantly
low weight
Events and
associated mood
change
Over-evaluation of shape and
weight and their control
12. Lectures
• Dalle Grave, R., Calugi, S. Cognitive Behavioral Therapy for Adolescents with Eating
Disorder. New York: Guilford Press, in press.
• Dalle Grave, R., & Cooper, Z. (2016). Enhanced cognitive behavior treatment adapted for
younger patients. In T. Wade (Ed.), Encyclopedia of Feeding and Eating Disorders (pp. 1-
8). Singapore: Springer Singapore.
• Dalle Grave, R. (2019). Cognitive-behavioral therapy in adolescent eating disorders. In J.
Hebebrand & B. Herpertz-Dahlmann (Eds.), Eating Disorders and Obesity in Children and
Adolescents (pp. 111-116). Philadelphia: Elsevier.
An overview of CBT-E for the younger patients
13. Goals
1. To engage patients in the treatment and involve them actively in the process of
change
2. To remove the eating disorder psychopathology, i.e. the dietary restraint and
restriction (and low weight if present), extreme weight control behaviours, and
preoccupation with shape, weight, and eating
3. To correct the mechanisms maintaining the eating disorder psychopathology
4. To ensure lasting change
An overview of CBT-E for the younger patients
14. General strategies
• It never adopts "prescriptive" or "coercive" procedures
• Patients are never asked to do things that they do not agree to do, as this may increase their
resistance to change
• The key strategy is to collaboratively create a personal formulation of the main processes
maintaining the patient’s individual psychopathology, as these will become the targets of
treatment
• Patients are educated about the processes in their personal formulation, and actively involved in
the decision to address them
• If they do not reach the conclusion that they have a problem to address, the treatment cannot
start or must be suspended, but this is a very rare occurrence
An overview of CBT-E for the younger patients
15. General strategies (cont.)
• The eating disorder psychopathology is addressed via a flexible set of sequential
cognitive and behavioural strategies and procedures, integrated with progressive patient
education
• To achieve cognitive change, patients are encouraged to observe, using real-time self-
monitoring, how the processes in their personal formulation operate in real life
• Patients are asked to make gradual behavioural changes and analyse their effects and
implications on their way of thinking.
• In the later stages of CBT-E, the treatment focuses on helping patients recognise the
early warning signs of eating disorder mind-set reactivation, and to decentre from it
quickly, thereby avoiding relapse
An overview of CBT-E for the younger patients
16. Structure
• Treatment duration
• 2 pre-treatment assessment
• 30–40 fifty-minute individual sessions in patients with a BMI between the 3rd and 25th
centile, and 20 sessions in those with a BMI > the 25th
• 3 post-treatment review sessions (after 4-12-20 weeks)
An overview of CBT-E for the younger patients
17. Structure
• Parent involvement
• One 50 minute sessions only with parents
• To identify and address any family-related factors that might hinder the patient’s attempts to
change
• Four to six (in patients who are not underweight) or eight to ten (in patients who are
underweight) 15–20 minutes jointly sessions with patient and parents
• To inform parents about what is happening and the patient’s progress and are also be used to
discuss, with the patient’s prior agreement, how they might help the patient make changes
An overview of CBT-E for the younger patients
18. STEP ONE: STARTING WELL AND DECIDING TO CHANGE
• Engaging the patient in treatment and change
• Establishing real-time self-monitoring
• Establishing collaborative in-session weighing
• Providing education
• Jointly creating the personal formulation
• Introducing a pattern of regular eating
• Thinking about addressing weight regain (in underweight patients)
• Involving parents
REVIEW SESSIONS*
• Conducting a joint review of progress
• Identifying emerging barriers to change
• Reviewing the formulation
• Deciding whether to use the broad form of
CBT-E
• Planning the rest of treatment
STEP TWO: ADDRESSING THE CHANGE
Focused CBT-E modules
• Underweight & Undereating (in underweight patients)
• Body Image
• Dietary Restraint
• Events and Mood Changes
• Setbacks & Mindsets
Broad CBT-E modules
• Clinical Perfectionism
• Core Low Self-Esteem
• Interpersonal Difficulties
• Mood Intolerance
STEP THREE: ENDING WELL
• Ensuring that progress is maintained
• Minimizing the risk of relapse
*One after Step One in non-underweight patients;
every 4 weeks in underweight patients
POST-REVIEW SESSIONS
After 4, 12 and 20 weeks
ASSESSMENT/PREPARATION CBT-E Map for younger patients
19. CBT-E and the younger patient
Topics
1. Eating disorders in younger patients
2. An overview of CBT-E for the younger patients
3. Effectiveness of CBT-E for the younger patients
4. Influence on the health policy
20. CBT-E and the younger patient
Topics
1. Eating disorders in younger patients
2. An overview of CBT-E for the younger patients
3. Effectiveness of CBT-E for the younger patients
4. Influence on the health policy
21. • 46 patients (13-17 years) with AN
• 40 sessions of CBT-E + 1 session with parents and 8 jointly session with patient and parents
• Non concomitant treatment
Anorexia Nervosa Verona Study
Dalle Grave R, Calugi, S, Doll HA, Fairburn CG, BRAT 2013
0
10
20
30
40
0 40 100
0
1
2
3
4
0 40 100
Weeks Weeks
EDE-Q
BMI
centile
Completers 63%
22. CBT-E per adolescenti e adulti con anoressia nervosa
Calugi S, Dalle Grave R, Sartirana M, Fairburn CG, J Eat Disord 2015
Significantly more adolescents reached the
goal BMI than adults (65.3% vs. 36.5%; P =
0.003).
The mean time required by the adolescents
to restore body weight was about 15 weeks
less than that for the adults (14.8 (SE = 1.7)
weeks vs. 28.3 (SE = 2.0) weeks, log-rank =
21.5, P < 0.001
23. • Sixty-eight adolescent patients with an eating disorder and BMI centile corresponding to an adult BMI > 18.5
• 40 sessions of CBT-E + 1 session with parents and 4 jointly session with patient and parents
• Non concomitant treatment
Not Underweight Verona Study
Dalle Grave R, Calugi S, Sartirana M, Fairburn CG, BRAT 2015
0
20
40
60
80
100
ITT Completers
Response
rate (%) Completers 75%
26. CBT-E and the younger patient
Topics
1. Eating disorders in younger patients
2. An overview of CBT-E for the younger patients
3. Effectiveness of CBT-E for the younger patients
4. Influence on the health policy
27. Reccomended psychological treatments
NICE guideline May 2017 – NG69
Bulimia Nervosa Binge-Eating
Disorder
Anorexia Nervosa OSFED
Adults GSH
If it is ineffective
CBT-ED
GSH
If it is ineffective
CBT-ED
CBT-ED o “Mantra”
o SSCM
If it is ineffective
FPT
Treatments for the
ED it most closely
resembles
Young people FT-BN
If it is ineffective
CBT-ED
GSH
If it is ineffective
CBT-ED
FT-AN
If it is ineffective
CBT-ED o ANFT
Treatments for the
ED it most closely
resembles
AFP-AN = Adolescent- Focused Psychotherapy for Anorexia Nervosa; CBT-ED = Cognitive Behavior Therapy for
Eating Disorders; GSH = Guided Self-Help; FPT= Focal psychodynamic therapy: MANTRA = Maudsley Anorexia
Nervosa Treatment for Adults; OSFED = other specified feeding and eating disorders; SSCN = Specialist
Supportive Clinical Management
29. • CBT-E is a promising treatment for adolescents with eating disorder
• It is well accepted by adolescents, probably due to its collaborative approach, which
grants ambivalent young patients a feeling of being in control
• The transdiagnostic nature of CBT-E makes it suitable for treating all the main eating
disorders that afflict adolescent patients
• The promising results obtained in cohort studies suggests, as recommended by NICE,and
also in real-world settings suggest that CBT-E for adolescents is a promising treatment
for adolescents with eating disorders
• Future studies should compare CBT-E with FBT across the full range of eating disorder
presentations to provide useful information regarding treatment in adolescents and to
identify moderators and mediators of the twos
Conclusions